InsidersTradesSigma
Track the 현대바이오 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 현대바이오 has logged 6 insider filings. Market capitalisation: €620.5bn. The latest transaction was disclosed on 30 June 2026 (Purchase). Among the most active insiders: 씨앤팜. The full history is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Hyundai Bio 是一家在XKRX市场上市的健康和制药公司。它专注于开发创新的生物制药解决方案。